Patient-Helpdesk.com

biktarvy gilead patient assistance program

by Duane Bogisich PhD Published 1 year ago Updated 1 year ago
image

Biktarvy does not cure HIV infection or AIDS. Patient Assistance Programs Gilead’s U.S. Advancing Access ® program provides assistance to appropriate patients in the United States who are uninsured, underinsured or who need financial assistance to pay for their medications, including Biktarvy.

Full Answer

How do I get help paying for Biktarvy?

Call the Advancing Access® Patient Support Program at 1-800-226-2056 1-800-226-2056 to talk to a specialist who can help you. The specialist can find programs to help you with insurance coverage and financial support to pay for BIKTARVY. If you are uninsured, there is immediate help available.

What is the Biktarvy advancing access co-pay program?

Biktarvy Advancing Access Co-pay Program: Commercially insured patients may save up to a maximum of $7200 per year; for additional information contact the program at 800-226-2056.

How can I access Gilead therapies outside of the United States?

If you are located outside the United States, you may select one of the following available country websites to access relevant information available for you. Our U.S. patient support programs help make Gilead therapies accessible for individuals who need information regarding insurance and financial support. These programs include:

How do I get help with Gilead advanced access?

Call the Advancing Access® Patient Support Program at 1-800-226-2056 1-800-226-2056 to talk to a specialist who can help with a benefits investigation, or go to www.GileadAdvancingAccess.com and click on “Uninsured 24/7 Support” for immediate help. You may be able to receive the medication free of charge.

How many studies are there for Biktarvy?

What is the renal monitoring for biktarvy?

How to contact Gilead Sciences?

What drugs can decrease the concentration of biktarvy?

Does Biktarvy cure HIV?

Does Biktarvy require a blood test?

Where is Gilead located?

See 2 more

About this website

image

Can I get Biktarvy for free?

If you are eligible to receive your Biktarvy prescription through the patient assistance program, your medication will be free. We charge a flat monthly price of $49 per medication to cover the cost of our services.

What is Gilead Advancing Access Program?

Advancing Access® Gilead's Advancing Access program helps patients understand their coverage and identify financial support options to access their Gilead HIV treatment, HIV prevention medication and COVID-19 medication Veklury®, remdesivir.

What is the copay for Biktarvy?

$0 co-pay* with no monthly limit.

Does Gilead copay card expire?

Have no fear, the cards are not expired, and you can still fill your PrEP prescription. Gilead has updated their RxBIN, RxPCN, RxGRP, and anyone who previously had a 9-digit Member ID now has a new 11 digit Member ID. This can be done while you're at the pharmacy.

How much is Genvoya a month?

Genvoya Coupon & Prices - Cost $49 per month.

Is PrEP free with Gilead?

For uninsured clients, Gilead's Patient Assistance Program will provide Truvada® for PrEP free of charge. For insured clients, Gilead's Copayment Assistance Program will cover up to $7,200 annually in Truvada® medication costs.

How much is a 30 day supply of Biktarvy?

The cost for Biktarvy oral tablet (50 mg-200 mg-25 mg) is around $3,783 for a supply of 30 tablets, depending on the pharmacy you visit.

How much does a one month supply of Biktarvy cost?

How much does Biktarvy cost without insurance? Without insurance coverage, the average monthly cost of Biktarvy (30, 50-200-25 mg tablets) is $7,797, or a little over $90,000 for one year of treatment.

What to do if you run out of Biktarvy?

What if I run out of Biktarvy?you could use an app on your phone to set a daily reminder or alarm.you can get into a routine of taking it at the same time each day (your daily dose at breakfast, dinner, or bedtime)you can use a pill box that may help you organize your medicines better.

What company makes Biktarvy?

7, 2018-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration ( FDA ) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen (STR) for the treatment of HIV-1 infection.

Is Truvada being discontinued?

From April 1, 2020 the brand name Truvada, manufactured by Gilead, commonly used as PrEP and treatment for HIV has been removed from the Pharmaceutical Benefits Scheme (PBS). However, other generic brands are still available for both HIV prevention and treatment.

How does a copay card work?

How do copay cards work? The idea behind copay cards is to reduce the total out-of-pocket expense for the patient. When you use one, your health insurance pays some of the cost and then the manufacturer pays part or all of the cost that you're responsible for through your copay or coinsurance.

What part of the country is Gilead?

Gilead is situated in modern-day Jordan, corresponding roughly to the Irbid, Ajloun, Jerash and Balqa Governorates. Gilead is also the name of three people in the Hebrew Bible, and a common given name for males in modern-day Israel.

What is ViiV connect?

What Is ViiVConnect? ViiVConnect provides comprehensive information to help healthcare professionals, pharmacists, patient representatives, and patients explore ways to access prescribed ViiV Healthcare medications.

What is Gilead in the handmaids tale?

The Republic of Gilead, colloquially referred to as simply Gilead or the "Divine Republic", is the totalitarian, theonomic, and neo-Puritanical regime that takes over most of the continental United States of America in The Handmaid's Tale. The regime can be seen as the overall main antagonist of the novel.

Does Gilead cover Descovy?

If you have commercial insurance The Gilead Advancing Access co-pay coupon card might help you save. If you are commercially insured and eligible, the co-pay coupon card covers up to $7,200 in co-pays per year with no monthly limit for DESCOVY for PrEP.

What is BIKTARVY®?

BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 55 pounds. It can either be used in people who have never taken HIV-1 medicines before, or people who are replacing their current HIV-1 medicines and whose healthcare provider determines they meet certain requirements.

What is Gilead Advancing Access?

If your healthcare provider has already determined that a Gilead treatment is right for you, then the Gilead Advancing Access® program is committed to helping you afford your medication every step of the way.

How much does Biktarvy weigh?

BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in adults and children who weigh at least 55 pounds.

Can you take Biktarvy with other medicines?

BIKTARVY and other medicines may affect each other. Keep a list of all your medicines and show it to your healthcare provider and pharmacist, and ask if it is safe to take BIKTARVY with all of your other medicines. If you are pregnant or plan to become pregnant.

Does Biktarvy cause nausea?

The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away.

Does Biktarvy make HBV worse?

Worsening of hepatitis B (HBV) infection. Your healthcare provider will test you for HBV. If you have both HIV-1 and HBV and stop taking BIKTARVY, your HBV may suddenly get worse. Do not stop taking BIKTARVY without first talking to your healthcare provider, as they will need to monitor your health, and may give you HBV medicine.

Does Biktarvy affect your immune system?

Serious side effects of BIKTARVY may also include: Changes in your immune system. Your immune system may get stronger and begin to fight infections that may have been hidden in your body. Tell your healthcare provider if you have any new symptoms after you start taking BIKTARVY.

What drugs can decrease the concentration of bikarvy?

Enzymes/transporters: Drugs that induce P-gp or induce both CYP3A and UGT1A1 can substantially decrease the concentration of components of BIKTARVY. Drugs that inhibit P-gp, BCRP, or inhibit both CYP3A and UGT1A1 may significantly increase the concentrations of components of BIKTARVY.

What should be assessed prior to or when initiating, and during treatment?

Prior to or when initiating, and during treatment: As clinically appropriate, assess serum creatinine, CrCl, urine glucose, and urine protein in all patients. In patients with chronic kidney disease, assess serum phosphorus.

Is Biktarvy a complete regimen?

BIKTARVY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing ≥25 kg who have no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies per mL) on a stable ARV regimen with no history of treatment failure and no known resistance to any component of BIKTARVY.

Can you take Biktarvy with dofetilide?

Coadministration: Do not use BIKTARVY with dofetilide or rifampin.

Can biktarvy be discontinued?

Discontinue BIKTARVY if clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity develop, including hepatomegaly and steatosis in the absence of marked transaminase elevations.

Can you breastfeed if you have HIV?

Lactation: Women infected with HIV-1 should be instructed not to breastfeed, due to the potential for HIV-1 transmission.

Is Biktarvy safe for pregnancy?

Pregnancy: There is insufficient human data on the use of BIKTARVY during pregnancy. Dolutegravir, another integrase inhibitor, has been associated with neural tube defects. Discuss the benefit-risk of using BIKTARVY during pregnancy and conception. An Antiretroviral Pregnancy Registry (APR) has been established. Available data from the APR for FTC shows no difference in the rates of birth defects compared with a US reference population.

How many studies are there for Biktarvy?

The approval of Biktarvy is supported by data from four ongoing Phase 3 studies: Studies 1489 and 1490 in treatment-naïve HIV-1 infected adults, and Studies 1844 and 1878 in virologically suppressed adults. The trials are comprised of a diverse population of 2,415 participants, including a wide range of adult age groups and races/ethnicities.

What is the renal monitoring for biktarvy?

Renal monitoring: Prior to or when initiating Biktarvy and during therapy, assess serum creatinine, CrCl, urine glucose, and urine protein in all patients as clinically appropriate. In patients with chronic kidney disease, also assess serum phosphorus.

How to contact Gilead Sciences?

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

What drugs can decrease the concentration of biktarvy?

Enzymes/transporters: Drugs that induce P-gp or induce both CYP3A and UGT1A1 can substantially decrease the concentration of components of Biktarvy. Drugs that inhibit P-gp, BCRP, or inhibit both CYP3A and UGT1A1 may significantly increase the concentrations of components of Biktarvy.

Does Biktarvy cure HIV?

Gilead plans to present data from these studies at scientific conferences in 2018. Biktarvy does not cure HIV infection or AIDS.

Does Biktarvy require a blood test?

Biktarvy does not require testing for HLA-B*5701, has no food intake requirements, and has no baseline viral load or CD4 count restrictions. According to Biktarvy’s Prescribing Information, prior to or when initiating treatment with Biktarvy, healthcare providers should test for hepatitis B virus (HBV) infection and renal function, ...

Where is Gilead located?

Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City , California . For nearly 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention, testing and linkage to care, and cure research.

What is the advancing access program?

Advancing Access patient assistance program, which provides Gilead medicines at no cost for qualified patients that meet the program’s eligibility criteria.

What is LEAP in healthcare?

The Letairis Education and Access Program (LEAP) helps patients understand their coverage and identify financial support options to access Letairis® (ambrisentan). The program offerings include:

What is Zydelig AccessConnect?

The Zydelig AccessConnect program helps patients understand their coverage and identify financial support options to access Zydelig ® (idelalisib). The program offerings include:

Does Zydelig provide patient assistance?

Referral to the Zydelig patient assistance program, which provides Zydelig at no cost for qualified patients that meet the program’s eligibility criteria.

What is biktarvy used for?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.

How much can you save on Biktarvy?

Biktarvy Advancing Access Co-pay Program: Eligible commercially insured patients may save up to a maximum of $7200 per year with no monthly limits; for additional information contact the program at 800-226-2056.

Is Biktarvy a generic?

Biktarvy is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Biktarvy availability . This Biktarvy price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

How much does Biktarvy cost?

Typically a person taking BIKTARVY pays between $0 and $5 per month. If you are a part of the Extra Help Program, you can expect to pay between $4 and $9 per month. If you are unsure whether you qualify for the Extra Help Program and would like more information, click here. The list price of BIKTARVY is $3,090 per month.

What is WAC in Biktarvy?

List price is also known as wholesale acquisition cost or WAC. WAC is listed as of April 19, 2019, for a 30-day supply of BIKTARVY.

How many studies are there for Biktarvy?

The approval of Biktarvy is supported by data from four ongoing Phase 3 studies: Studies 1489 and 1490 in treatment-naïve HIV-1 infected adults, and Studies 1844 and 1878 in virologically suppressed adults. The trials are comprised of a diverse population of 2,415 participants, including a wide range of adult age groups and races/ethnicities.

What is the renal monitoring for biktarvy?

Renal monitoring: Prior to or when initiating Biktarvy and during therapy, assess serum creatinine, CrCl, urine glucose, and urine protein in all patients as clinically appropriate. In patients with chronic kidney disease, also assess serum phosphorus.

How to contact Gilead Sciences?

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

What drugs can decrease the concentration of biktarvy?

Enzymes/transporters: Drugs that induce P-gp or induce both CYP3A and UGT1A1 can substantially decrease the concentration of components of Biktarvy. Drugs that inhibit P-gp, BCRP, or inhibit both CYP3A and UGT1A1 may significantly increase the concentrations of components of Biktarvy.

Does Biktarvy cure HIV?

Gilead plans to present data from these studies at scientific conferences in 2018. Biktarvy does not cure HIV infection or AIDS.

Does Biktarvy require a blood test?

Biktarvy does not require testing for HLA-B*5701, has no food intake requirements, and has no baseline viral load or CD4 count restrictions. According to Biktarvy’s Prescribing Information, prior to or when initiating treatment with Biktarvy, healthcare providers should test for hepatitis B virus (HBV) infection and renal function, ...

Where is Gilead located?

Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City , California . For nearly 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention, testing and linkage to care, and cure research.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9